Edition:
United States

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

24.83USD
14 Dec 2017
Change (% chg)

$-0.39 (-1.55%)
Prev Close
$25.22
Open
$25.25
Day's High
$25.25
Day's Low
$24.40
Volume
113,863
Avg. Vol
61,781
52-wk High
$40.56
52-wk Low
$19.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
FY 2015 Dec '15 12.52 -0.087
Sep '15 12.50 0.032
Jun '15 12.36 -0.085
Mar '15 12.93 0.068
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 10.98 12.60 7.15 7.04
Quarter Ending Mar-18 2 9.77 12.50 7.05 --
Year Ending Dec-17 7 49.08 50.70 45.24 47.16
Year Ending Dec-18 7 47.01 50.50 28.18 39.14
Earnings (per share)
Quarter Ending Dec-17 8 -0.56 -0.45 -0.82 -0.30
Quarter Ending Mar-18 4 -0.57 -0.45 -0.78 --
Year Ending Dec-17 8 -1.90 -1.74 -2.20 -0.80
Year Ending Dec-18 8 -2.42 -1.58 -2.97 -1.62
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta -- 0.82 0.91
Price to Sales (TTM) 12.82 117.54 5.90
Price to Book (MRQ) -- 23.08 5.74
Price to Tangible Book (MRQ) -- 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 53.57 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.05 -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago 1.43 30.49 5.56
Sales - 5 Yr. Growth Rate -- 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -1,132.90 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago -664.24 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate -- 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 3.18 5.63 3.57
LT Debt to Equity (MRQ) -- 16.33 13.26
Total Debt to Equity (MRQ) -- 18.85 19.22
Interest Coverage (TTM) -- -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -67.32 -- --
EBITD - 5 Yr. Avg -- -215.54 15.70
Operating Margin (TTM) -68.43 -635.70 6.77
Operating Margin - 5 Yr. Avg. -- -232.57 11.08
Pre-Tax Margin (TTM) -69.43 -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -- -232.71 11.49
Net Profit Margin (TTM) -69.43 -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -- -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 674,600 22,216,302 857,902,259
Net Income/Employee (TTM) -468,387 -2,116,531 100,310,105
Receivable Turnover (TTM) -- 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.39 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -26.80 -9.39 11.35
Return on Assets - 5 Yr. Avg. -- 0.13 12.32
Return on Investment (TTM) -46.06 -11.69 14.48
Return on Investment - 5 Yr. Avg. -- 3.37 16.13
Return on Equity (TTM) -- -36.44 16.06
Return on Equity - 5 Yr. Avg. -- 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -0.92 -0.88 --
EPS (TTM) % -333.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.73%
# of Holders: 121
Total Shares Held: 10,066,482
3 Mo. Net Change: 3,105,737
# New Positions: 31
# Closed Positions: 4
# Increased Positions: 79
# Reduced Positions: 15
# Net Buyers: 64
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.